FDA Inspection 1095554 — University of Pittsburgh Cancer Institute Cancer Service
The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on June 24, 2019 in Erie, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 24, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Erie, PA (United States)